About BBCS

Who We Are:

Privately owned and headquartered in the Pacific Northwest, Blood Bank Computer Systems, Inc., (BBCS) has been one of the blood banking industry’s complete software solutions for information and risk management since 1987. BBCS is committed to developing and providing safe and effective software solutions, which provide management with the tools necessary to minimize the risks associated with operating a blood center and a cross match lab. BBCS works closely with their dynamic client group and partners to continually improve the product line and provided services. On October 22, 2004 the FDA 510(k) cleared BBCS Release 5.0. This was the first 510(k) clearance for BBCS since the original Release 4.3 (#BK96004) was cleared on October 15, 1997 BBCS has received the following 510(k) clearances for BBCS products:

BBCS Primary Application 5.0P 510(k) #BK040056 cleared 10/22/04
BBCS Lab Application 5.0L 510(k) #BK040087 cleared 2/15/05
BBCS Mobile Application 5.0M 510(k) #BK050013 cleared 6/1/05
BBCS Hospital Application 1.0H 510(k) #BK090081 cleared 1/20/10
BBCS BloodTrack Interface Application 1.0.0., 510(k) #BK120028, cleared 6/21/2012

Whom We Serve:

BBCS serves 30 community blood bank facilities in 18 different states with a range in size from 10,000 to over 200,000 units drawn annually. Overall, BBCS supports over 1.3 million units annually and the largest centralized cross match lab in the USA. Continued dedication to quality and service has made BBCS a leader in the blood banking community.

Blood Bank Computer System, Inc. is a member of the America Association of Blood Banks and a contributing sponsor of the National Blood Foundation. Please visit our list of current clients.

About the Blood Bank Control System:

The BBCS 5.0 Primary Application received FDA 510(k) clearance on October 22, 2004, and the BBCS 5.0L Lab Interface Application received FDA 510(k) clearance on February 15, 2005.

The Blood Bank Control System, 4.4, in its entirety (both the donor and patient modules), was 510(k) cleared by the FDA on October 15, 1997, under the following number: BK960044.